References
- Chisolm J J, Jr. The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood. J Pediatr 1968; 73: 1–38
- Chisolm J J, Jr. Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures. Environ Health Perspect 1990; 89: 67–74
- Cory-Slechta D A. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J Pharmacol Exp Ther 1988; 246: 84–91
- Maiorino R M, Barry T J, Aposhian H V. Determination and metabolism of dithiol-chelating agents: electrolytic and chemical reduction of oxidized dithiolsin urine. Annal Biochem 1987; 160: 217–226
- Aposhian H V, Aposhian M M. Meso-2, 3-dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu Rev Pharmacol Toxicol 1990; 30: 279–306
- Aaseth J. Recent advances in the therapy of metal poisonings with chelating agents. Hum Toxicol 1983; 2: 257–272
- Cory-Slechta D A, Weiss B, Cox C. Mobilization and redistribution of lead over the course of CaEDTA chelation therapy. J Pharmacol Exp Ther 1987; 243: 804–813
- Marino P E, Landigran P J, Graef J, et al. A case report of lead paint poisoning during renovation of a Victorian farmhouse. Am J Public Health 1990; 80: 1183–1185